Autophagy induction for the treatment of cancer. Issue 10 (2nd October 2016)

• Record Type: Journal Article
• Authors: Pietrocola, Federico; Pol, Jonathan; Vacchelli, Erika; Baracco, Elisa E.; Levesque, Sarah; Castoldi, Francesca; Maiuri, Maria Chiara; Madeo, Frank; Kroemer, Guido
• Is Part Of: Autophagy. Volume 12:Issue 10(2016)
• Page Start: 1962
• Page End: 1964
• Publication Date: 2016-10-02
• Subjects: acetylation -- caloric restriction mimetics -- hydroxycitrate -- immunosurveillance -- regulatory T cells -- spermidine; Autophagic vacuoles -- Periodicals; Apoptosis -- Periodicals; Cell death -- Periodicals; Lysosomes -- Periodicals; Degeneration (Pathology) -- Periodicals; Autophagy -- Periodicals; Cell Death -- Periodicals; Lysosomes -- Periodicals; Periodicals; 571.936
• DOI: 10.1080/15548627.2016.1214778
• Languages: English
• ISSNs: 1554-8627

Abstract

ABSTRACT: Cancer can be viewed in 2 rather distinct ways, namely (i) as a cell-autonomous disease in which malignant cells have escaped control from cell-intrinsic barriers against proliferation and dissemination or (ii) as a systemic disease that involves failing immune control of aberrant cells. Since macroautophagy/autophagy generally increases the fitness of cells as well as their resistance against endogenous or iatrogenic (i.e., relating to illness due to medical intervention) stress, it has been widely proposed that inhibition of autophagy would constitute a valid strategy for sensitizing cancer cells to chemotherapy or radiotherapy. Colliding with this cell-autonomous vision, however, we found that immunosurveillance against transplantable, carcinogen-induced or genetically engineered cancers can be improved by pharmacologically inducing autophagy with caloric restriction mimetics. This positive effect depends on autophagy induction in cancer cells and is mediated by alterations in extracellular ATP metabolism, namely increased release of immunostimulatory ATP and reduced adenosine-dependent recruitment of immunosuppressive regulatory T cells into the tumor bed. The combination of autophagy inducers and chemotherapeutic agents is particularly efficient in reducing cancer growth through the stimulation of CD8 + T lymphocyte-dependent anticancer immune responses.